Cite
HARVARD Citation
Peyrin-Biroulet, L. et al. (2022). Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. Lancet gastroenterology and hepatology. pp. 128-140. [Online].